By Gazette Staff Novavax of Rockville scored a significant victory Monday when it won a federal contract worth up to $179 million to continue developing its new vaccines for seasonal and pandemic flu. The company this week also announced a licensing deal with a South Korean pharmaceutical company for producing and marketing flu vaccines there […]
New controversy surrounding flu vaccination
By Annie Guest ELIZABETH JACKSON: There’s renewed controversy surrounding influenza vaccines today with some studies showing that people immunised against the seasonal flu might have been at greater risk during the swine flu outbreak. An infectious diseases expert professor Peter Collignon has called for a review of Australia’s flu vaccine policy in light of this […]
Rethink flu vaccine policy, says health expert
By Adam Cresswell, Health Editor A leading flu expert has called for a rethink of flu vaccine policy, in the light of evidence suggesting people vaccinated against seasonal flu shortly before swine flu swept the globe had a greater risk of serious illness from the new strain. Peter Collignon, professor of infectious diseases and microbiology […]
Scientific Fraud May Be More Widespread Than Thought, Poll Says
By Elizabeth Lopatto June 18 (Bloomberg) — About 1,000 potential incidents of fabrication, falsification or plagiarism in scientific research go unreported every year, according to a survey that suggests such misconduct is far more prevalent than suspected. On average, the Department of Health and Human Services’ Office of Research Integrity receives only 24 reports of […]
Public want inquiry into MMR
More than three-quarters of the population believe there should be a full public inquiry into the combined measles, mumps and rubella vaccine, according to a recent survey. Some 76 per cent of the 1,001 people surveyed believe the facts about the controversial MMR jab, which has been blamed for a rise in autism and bowel […]
- « Previous Page
- 1
- …
- 337
- 338
- 339
- 340
- 341
- …
- 448
- Next Page »
